Literature DB >> 14623115

The CD99 signal enhances Fas-mediated apoptosis in the human leukemic cell line, Jurkat.

Kyeong Cheon Jung1, Nam Hyun Kim, Weon Seo Park, Seong Hoe Park, Youngmee Bae.   

Abstract

The CD99 antigen has been implicated in various cellular processes, including apoptosis in T cells. Previously, we reported two monoclonal antibodies that recognize different epitopes of the CD99 molecule, named DN16 and YG32. In this study, we investigated the role of each CD99 epitope in T cell apoptosis. Unlike the DN16 epitope, CD99 ligation via the YG32 epitope failed to induce T cell death. Surprisingly, however, the YG32 signal enhanced Fas-mediated apoptosis in Jurkat T cells. Augmentation of Fas-mediated apoptosis by YG32 ligation was inhibited by treatment with either of the caspase inhibitors z-VAD-fmk or z-IETD-fmk, and YG32 ligation appeared to induce Fas oligomerization. These results suggest that each CD99 epitope plays a distinct role in T cell biology, especially in T cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623115     DOI: 10.1016/s0014-5793(03)01224-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Expression of CD99 in pleomorphic carcinomas of the lung.

Authors:  Seong-Ho Yoo; Jungho Han; Tae Jin Kim; Doo Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

2.  CD99-Derived Agonist Ligands Inhibit Fibronectin-Induced Activation of β1 Integrin through the Protein Kinase A/SHP2/Extracellular Signal-Regulated Kinase/PTPN12/Focal Adhesion Kinase Signaling Pathway.

Authors:  Kyoung-Jin Lee; Yuri Kim; Yeon Ho Yoo; Min-Seo Kim; Sun-Hee Lee; Chang-Gyum Kim; Kyeonghan Park; Dooil Jeoung; Hansoo Lee; In Young Ko; Jang-Hee Hahn
Journal:  Mol Cell Biol       Date:  2017-06-29       Impact factor: 4.272

Review 3.  CD99 in malignant hematopoiesis.

Authors:  Atham Ali; Vijaya Pooja Vaikari; Houda Alachkar
Journal:  Exp Hematol       Date:  2021-12-14       Impact factor: 3.249

4.  Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.

Authors:  Chang Ohk Sung; Young H Ko; Sanghui Park; Kihyun Kim; Wonseog Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

5.  Involvement of glycoreceptors in galactoxylomannan-induced T cell death.

Authors:  Eva Pericolini; Elena Gabrielli; Elio Cenci; Magdia De Jesus; Francesco Bistoni; Arturo Casadevall; Anna Vecchiarelli
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

6.  High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia.

Authors:  Larizbeth A Romero; Takamitsu Hattori; Mohamed A E Ali; Gayatri Ketavarapu; Akiko Koide; Christopher Y Park; Shohei Koide
Journal:  J Mol Biol       Date:  2021-12-24       Impact factor: 5.469

7.  Malignant fibrous histiocytoma with in-transit metastasis.

Authors:  Taku Fujimura; Masayuki Sugawara; Takahiro Haga; Yoshiyuki Kariya; Ryuhei Okuyama; Hachiro Tagami; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2011-08-17

8.  Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.

Authors:  Angela Oranger; Giacomina Brunetti; Claudia Carbone; Graziana Colaianni; Teresa Mongelli; Isabella Gigante; Roberto Tamma; Giorgio Mori; Adriana Di Benedetto; Marika Sciandra; Selena Ventura; Katia Scotlandi; Silvia Colucci; Maria Grano
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

Review 9.  CD99 at the crossroads of physiology and pathology.

Authors:  Michela Pasello; Maria Cristina Manara; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2018-01-06       Impact factor: 5.782

10.  Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226.

Authors:  Minchan Gil; Hyo-Kyung Pak; Seo-Jeong Park; A-Neum Lee; Young-Soo Park; Hyangsin Lee; Hyunji Lee; Kyung-Eun Kim; Kyung Jin Lee; Dok Hyun Yoon; Yoo-Sam Chung; Chan-Sik Park
Journal:  Immune Netw       Date:  2015-10-26       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.